Recreating the Natural Wound Healing Environment
ActiGraft, based on RedDress’ proprietary patented technology, is the first wound care product that enables health care providers to produce—in real time—in vitro blood clots from a patient’s whole blood. Once applied, the blood clot serves as a protective covering, biologic scaffold and wound microenvironment to promote the natural wound healing processes of the body.
Can be easily prepared at the patient’s bedside in 12 minutes
Provides significant savings in nursing costs and simplifies wound treatment
Significantly faster healing with less wound interaction and patient pain
Seamlessly integrates into current chronic wound treatment practices
Enables front line staff to easily execute ongoing wound treatment
Uses the patient’s own blood to promote the body’s natural healing processes
Standard of Care topical dressings address one or two aspects of a chronic wound bed. The ActiGraft dressing contains the provisional extracellular matrix acting not only as a scaffold, but as a signaling, binding and activating substrate that regulates the crosstalk between fibroblasts, keratinocytes, endothelial cells and key inflammatory cells - the big players in wound healing.
ActiGraft changes the way we treat chronic wounds by managing every stage of the wound healing process and taking the guesswork out of wound treatment.